Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-02-20 @ 8:08 PM
Study NCT ID:
NCT03659435
Status:
COMPLETED
Last Update Posted:
2019-09-19
First Post:
2018-08-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)
Sponsor:
SocraTec R&D GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bioequivalence | View |
Keywords: